Engineer - Engineering Tech Center - Parenteral Network at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
$63,000 – $165,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Expertise in Aseptic Processing and Parenteral Technologies (Equipment Preparation, Formulation, Filling, Freeze Drying, Isolation systems)
  • Strong knowledge in engineering sciences related to Process Engineering and secondary/tertiary loop disciplines (First Principles, unit operations, Equipment Flow Diagrams, Capability Calculations, Material & Energy Balances, Facilities fitness for use, Root Cause applications, Equipment/Unit Operation Changes/Improvements, new technologies, Scale-ups, Periodic Reviews, Process Safety, Maintenance/Reliability)
  • Ability to provide global technical expertise and support to manufacturing sites (Indy Parenteral (IPM), Fegersheim, Sesto, Suzhou, Research Triangle Park (RTP), Concord, Alzey), Global Facilities Delivery (GFD), development sites, external manufacturing organizations, and alliances
  • Experience in technical leadership, including partnering with technical staff, oversight of discipline activities, new technology development/assessments, creation/maintenance of Engineering Standards, Master specifications, and Best Practices
  • Capability to coach and mentor junior engineering staff
  • Knowledge of regulatory and corporate policy requirements, safety practices/procedures, and Quality expectations
  • Skills in technical evaluations, master planning, technology assessments, troubleshooting, root cause analysis, and problem resolution
  • Ability to review/prepare protocols and technical reports

Responsibilities

  • Provide technical and discipline leadership: partner with technical staff, oversee community activities, develop/assess new technologies, create/maintain Engineering Standards, Master specifications, and Best Practices; coach/mentor junior staff
  • Ensure safety and compliance: maintain personal/team compliance with regulatory/corporate policies, implement safety practices to prevent injuries, meet Quality expectations, monitor evolving regulatory requirements
  • Offer consultation: assist global sites with technical evaluations, master planning, technology assessments, troubleshooting, root cause analysis, and problem resolution
  • Facilitate knowledge sharing: provide ongoing technical support to site engineering groups (domestic/global), mentor Lilly engineers for technical development, develop site technical experts in Parenteral Engineering, review/prepare protocols and technical reports
  • Exert external influence: monitor/influence external codes/standards on Lilly’s behalf, communicate external learnings effectively

Skills

Process Engineering
Aseptic Processing
Unit Operations
Equipment Flow Diagrams
Capability Calculations
Material Balances
Energy Balances
Root Cause Analysis
Process Safety
Scale-up
Maintenance Reliability

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI